FACT Complex-targeting Curaxin CBL0137: Clinical Trials

1 trial of FACT Complex-targeting Curaxin CBL0137, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow FACT Complex-targeting Curaxin CBL0137: new trials by email Literature Review of FACT Complex-targeting Curaxin CBL0137 trials Research Report on FACT Complex-targeting Curaxin CBL0137

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Biospecimen Collection, Bone Marrow Aspirate, Bone Marrow Biopsy - Diffuse Midline Glioma, H3 K27-Altered, Metastatic Malignant Neoplasm in the Central Nervous System
Phase 1 / Phase 2RecruitingChildren's Oncology Group632022-01-282026-09-11

Conditions studied

Diffuse Intrinsic Pontine Glioma (1)  ·  Lymphoma (1)

Sponsors

Children's Oncology Group (1)

Countries

Australia (1)  ·  United States (1)

Top investigators

David S Ziegler (1)

NIH funding

UM1CA228823 (1)